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1. Introduction 
Metabolic acidosis in the rat results in increased 
renal gluconeogenesis and ammoniagenesis [1,2] . The 
site of stimulation for gluconeogenesis is phosphoenol 
pyruvate carboxykinase (PEPCK, EC 4.1.32) [3] but 
the rate determining step for ammoniagenesis is not 
clear. The relationship between the two processes is 
even less certain and there are studies which show an 
increase in gluconeogenesis without any change in 
ammoniagenesis [4,5] and conversely that gluconeo- 
genesis can be blocked without affecting ammonia- 
genesis [6]. An earlier proposal that enhancement of 
PEPCK may be important in augmenting ammonia- 
genesis [3] has been re-emphasised recently by Krebs 
and Vinay [7] . 3-Mercaptopicolinic acid (3-MPA) is 
an inhibitor of PEPCK [8-l 11. We have therefore 
used this substance to re-examine the relationship 
between ammonia and glucose production by the 
kidney in normal and acidotic rats. 
2. Materials and methods 
2.1. Experiments in vivo 
Adult Sprague-Dawley rats were used. Acidosis 
was produced by tube feeding 3 doses of 400 mM 
NHdCl(2.5 ml/l00 gm body weight) at 0800,200O 
and 0800 hours. Control animals received 400 mM 
NaCl and all rats were sacrificed 2 h after the last 
feed. Animals were anaesthetized and blood acid- 
base parameters measured as described previously [S] . 
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In experiments with 3-MPA, rats were fed 100 mg/kg 
3-MPA in 1% methyl cellulose or 0.9% NaCl in 1% 
methyl cellulose: they were anaesthetized 30 min 
later, the kidneys were rapidly removed, quick frozen 
and powdered in liquid nitrogen. The powder was 
extracted in 6% PCA for measurement of intermediates 
[121. 
2.2. Experiments in vitro 
For measurements of gluconeogenesis and ammonia- 
genesis in vitro, slices of kidney cortex were cut and 
incubated in Krebs-Ringer bicarbonate buffer as 
described previously [5] and glutamine, glutamate, 
glucose and ammonia were measured in neutralized 
samples of the medium [ 121. At the end of some 
experiments slices were rapidly removed, quick 
frozen, powdered and extracted in 6% PCA for 
measurement of glutamate and aspartate. 
3. Results 
3.1. Degree of acidosis 
NH4C1 produced significant metabolic acidosis, as 
the blood pH and plasma bicarbonate fell from the 
control value of 7.37 + 0.01 and 23.9 + 0.5 mM 
(n = 13) to values of 7.09 f. 0.2 and 12.3 + 1.7 (n = 7). 
3.2. Site of action of 3-MPA 
Intermediates measured 30 niin after the 3-MPA 
was given show an increase in 2-oxoglutarate, malate 
and aspartate, with a decrease in phosphoenolpyruvate 
and glycerol-3-phosphate. Glutamine and glutamate 
were unchanged. There was significant hypoglyca- 
emia at this time (table 1). Glucose production by 
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Table 2 
Effect of 3-MPA on gluconeogenesis 
Substrate 
0 mercaptopicolinate 
@moles glucose/- 
h g dry wt.) 
0.1 mM Mercaptopicolinate 
&moles Glucose/h g dry wt.) 
Fructose 2 mM 112.3 ?r 4.9 (17) 96.6 f 8.9 (9) 
Dihydroxy- 
acetone 2 mM 127.3 * 10.6 (8) 117.5 + 7.3 (10) 
Malate 2 mM 83.8 t 3.6 (18) 53.7 f 3.4c (9) 
Oxogluterate 
2mM 46.7 + 2.8 (6) 22.3 + 2.2’ (6) 
Fumarate 2 mM 107.1 f 7.4 (12) 44.5 k 2.3’ (12) 
Values are mean * s.e.m., for the numbers of observations in parentheses. 
’ Indicates statistical significance p < 0.001 compared with controls. 
cortical slices from fructose and dihydroxyacetone 
was not inhibited by 3-MPA while that from oxogluta- 
rate, fumarate and malate was significantly inhibited 
(table 2). These two sets of data show that 3-MPA 
acts at the PEPCK step to inhibit renal gluconeogenesis. 
3.3. Effect of 3-MPA on gluconeogenesis and 
ammoniagenesis 
With glutamine as substrate, 3-MPA inhibited 
ammoniagenesis (23%) and gluconeogenesis (82%). 
Kidney cortex slices from acidotic rats showed a 
significant increase in ammonia nd glucose produc- 
tion, both of which were inhibited by 3-MPA. How- 
ever, even with 3-MPG, slices from acidotic rats still 
produced more ammonia nd glucose than slices from 
controls (table 3). Glutamate output was unaffected 
by 3-MPA. 
3.4. Glutamine uptake and source of ammonia 
The contribution of the amide and ammo groups 
of glutamine to net ammonia production was calcu- 
lated [ 131. Kidney slices from acidotic rats showed 
Table 3 
Effect of 0.5 mM 3-MPA on ammonia, glucose and glutamate production from 2 mM glutamine 
Control Acidotic 
0 MPA 0.5 mM MPA 0 MPA 0.5 mM MPA 
Total &moles 373.0 f 12.6 287.1 f 8.2 535.4 k 20.1 380.8 f 13.5 
NHJh g dry wt.) (34) (32) (32) (32) 
Total &moles 38.0 f 1.7 6.7 f 1.2 78.6 f 4.0 13.6 + 1.4 
glucose/h g (35) (15) (36) (34) 
dry wt.) 
Total (nmoles 
glutamate/h g 
dry wt.) 
66.4 f 4.2 76.4 t 3.1 71.9 f 5.9 75.3 f 3.3 
(31) (32) (33) (34) 
Values are mean f s.e.m. for the numbers of observations in parentheses. 
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Table 4 
Effect of 3-MPA on the contribution of the amide and amino groups 
of glutamine (2 mM) to ammoniagenesis 
Slices 
Control 
Net ammonia 
production 
&moles/h g dry wt.) 
341.2 + 13.9 (34) 
Glutamine uptake 
(amide NH,) 
&moles/h g dry wt.) 
219.2 * 10.3 (34) 
Amino NH, 
&moles/h g dry wt.) 
122.0 f 12.2 (34) 
Control in 
0.5 mM MPA 
Acidotic 
257.9 f 8.2 (32) 197.8 + 7.9 (32) 60.1 + 7.1 (32) 
503.6 + 20.4 (31) 301.1 + 9.1 (31) 202.5 f 18.6 (31) 
Acidotic in 
0.5 mM MPA 354.6 + 13.7 (32) 240.2 f 9.0 (32) 114.4 + 13.5 (32) 
Values are mean f s.e.m., for the numbers of observations in parentheses. 
enhanced uptake of glutamine (table 4). 3-MPA did 
not affect glutamine uptake by slices from control 
rats whereas this was significantly inhibited in slices 
from acidotic rats. In control slices, depression of 
ammonia formation was due entirely to a reduction 
in amino ammonia while in acidotic slices there was 
reduction in deamidation and deamination with the 
latter being more severely depressed. 
3.5. Glutamate and aspartate in slices 
Glutamate and aspartate levels in slices incubated 
without 3-MPA were 12.2 + 0.6 (13) and 3.0 f 0.4 (8) 
I.tmol/mg Protein. In the presence of 3-MPA the 
glutamate levels did not change, 12.4 f 0.7 (13) but 
aspartate rose to 10.5 f 0.9 (10). 
4. Discussion 
Our studies in vivo and in vitro confirm that 3-MPA 
produces hypoglycemia and inhibits renal PEPCK. The 
metabolic profile we have found in the kidney of rats 
given 3-MPA is similar to that described for the liver 
[9,10]. We were unable to measure oxaloacetate but 
the increased levels of aspartate found probably 
reflect an increased level of oxaloacetate. 
3-MPA reduced the amount of ammonia formed 
from the amino group of glutamine, and this was 
linked with a reduction in gluconeogenesis. Glutamate 
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derived from glutamine probably has oxidation or 
gluconeogenesis as its major fate. In slices from 
control animals glutamate formation from glutamine 
remained unchanged with 3-MPA (table 3) but the 
amount of glutamate which was deaminated fell 
(table 4). In slices with or without 3-MPA the 
glutamate deaminated was 60 versus 120 pmol/h g 
dry wt. Glucose production in similar conditions 
was 6.7 and 38.0 pmol/h g dry wt. Therefore, with 
or without 3-MPA the amount of glutamate used in 
non-gluconeogenic pathways was the same (47 and 
46 pmol/h g). This indicates that it is the reduction 
in utilization of glutamate for gluconeogenesis which 
is responsible for the reduction in ammoniagenesis. 
Krebs and Vinay [7] have proposed that the 
increased ammonia production in acidosis is related 
to the stimulation of gluconeogenesis at the PECPK 
step. A decrease in 2-oxoglutarate leads to a displace- 
ment of glutamate dehydrogenase (EC 1.4.1.3) from 
equilibrium with resultant increased glutamate 
oxidation. Our data are in agreement with this, since 
in the reverse situation when there was inhibition of 
PEPCK we found elevated 2-oxoglutarate levels and 
decreased formation of ammonia from the glutamate 
derived from glutamine. 
In slices from acidotic animals 3-MPA actually 
depressed glutamine uptake and the NH3 production 
from both amide and amino groups was reduced. It 
has been shown in the acidotic rat that there is 
increased glutaminase activity as well as increased 
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transmitochondrial transport of glutamine. Our 
studies so far do not indicate which if either of these 
steps is affected by 3-MPA. 
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